Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory, Public Health Agency of Canada, St-Hyacinthe, Quebec, Canada.
Groupe de recherche en épidémiologie des zoonoses et santé publique, Université de Montréal, St-Hyacinthe, Quebec, Canada.
Environ Health Perspect. 2024 Feb;132(2):27005. doi: 10.1289/EHP13759. Epub 2024 Feb 13.
Lyme disease (LD) is emerging in Canada owing to the range expansion of the tick vector ().
Our objective was to estimate future LD incidence in Canada, and economic costs, for the 21st century with projected climate change.
Future regions of climatic suitability for were projected from temperature output of the North American Coordinated Regional Climate Downscaling Experiment regional climate model ensemble using greenhouse gas Representative Concentration Pathways (RCPs) 4.5 and 8.5. Once regions became climatically suitable for ticks, an algorithm derived from tick and LD case surveillance data projected subsequent increasing LD incidence. Three scenarios (optimistic, intermediate, and pessimistic) for maximum incidence at endemicity were selected based on LD surveillance, and underreporting estimates, from the United States. Health care and productivity cost estimates of LD cases were obtained from the literature.
Projected annual LD cases for Canada ranged from 120,000 to by 2050. Variation in incidence was mostly due to the maximum incidence at endemicity selected, with minor contributions from variations among climate models and RCPs. Projected annual costs were substantial, ranging from to a year by 2050. There was little difference in projected incidence and economic cost between RCPs, and from 2050 to 2100, because projected climate up to 2050 is similar for RCP4.5 and RCP8.5 (mitigation of greenhouse gas emissions captured in RCP4.5 does not impact climate before the 2050s) and by 2050 the most densely populated areas of the study region are projected to be climatically suitable for ticks.
Future incidence and economic costs of LD in Canada are likely to be substantial, but uncertainties remain. Because densely populated areas of Canada are projected to become endemic under conservative climate change scenarios, mitigation of greenhouse gas emissions is unlikely to provide substantial health co-benefits for LD. https://doi.org/10.1289/EHP13759.
由于蜱虫传播媒介的范围扩大,莱姆病(LD)在加拿大不断出现。
我们的目的是根据气候变化的预测,估算 21 世纪加拿大未来 LD 的发病率和经济成本。
使用温室气体代表性浓度路径(RCP)4.5 和 8.5 的北美协调区域气候降尺度实验区域气候模型集合的温度输出,对未来的蜱虫气候适宜区进行预测。一旦区域变得适合蜱虫生存,就会根据蜱虫和 LD 病例监测数据的算法预测随后 LD 发病率的增加。根据美国的 LD 监测和漏报估计,选择了三种最大流行发病率的情景(乐观、中间和悲观)。从文献中获得了 LD 病例的医疗保健和生产力成本估算。
预计到 2050 年,加拿大的 LD 年病例数将在 12 万至 之间。发病率的变化主要归因于选择的最大流行发病率,而气候模型和 RCP 之间的差异则较小。预计每年的费用都很高,从 到 不等。在 2050 年到 2100 年之间,RCP 之间的预测发病率和经济成本差异不大,因为到 2050 年为止,RCP4.5 和 RCP8.5 的预测气候相似(RCP4.5 中捕获的温室气体减排不会影响到 2050 年代之前的气候),到 2050 年,研究区域人口最密集的地区预计将适合蜱虫生存。
加拿大未来 LD 的发病率和经济成本可能会很高,但仍存在不确定性。由于加拿大人口密集地区预计将在保守的气候变化情景下流行,因此减少温室气体排放不太可能为 LD 提供实质性的健康协同效益。https://doi.org/10.1289/EHP13759.